MedTrace Logo

A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation

NCT03255824 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2020-05-13

Study results available
· View outcomes & findings →

Summary

Hypothesis: A combination of midazolam with dexmedetomidine for sedation during third molar surgery will provide 1) superior patient satisfaction, 2) superior operator satisfaction and 3) no significant hemodynamic or respiratory changes when compared to a sedation combination of midazolam, fentanyl and propofol for sedation during third molar surgery.

Conditions

  • Anesthesia

Interventions

DRUG

Dexmedetomidine and Midazolam

Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.

DRUG

Propofol, Midazolam, and Fentanyl

Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-20
Primary Completion
2019-08-23
Completion
2019-12-27
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03255824 on ClinicalTrials.gov